Paul Tudor Jones sees potential market rally after late October
Investing.com - Benchmark has reiterated its Buy rating on GSR III Acquisition Corp. (NASDAQ:GSRT) stock, maintaining its $19.00 price target, representing an 83% upside from the current price of $10.36. With a market capitalization of $302 million, InvestingPro data shows the stock trading near its 52-week low.
The research firm cited Terra Innovatum’s memorandum of understanding (MOU) with ATB Riva Calzoni for the preparation, development and production of the SOLO micro-reactor as a positive development.
Benchmark’s analysis recognizes GSR III’s commercial strategy, which utilizes existing fuel supply and known components and systems for the first-of-a-kind SOLO microreactor.
The firm also highlighted the planned commercial site outside St. Louis, Missouri, for prototype testing as another favorable indicator, rather than using a research or government facility.
According to Benchmark, the MOU with ATB establishes a critical manufacturing relationship with a capable partner, with Terra targeting a 2028 deployment date for the SOLO MMR (micro modular reactor).
In other recent news, Terra Innovatum Srl has made significant progress in the regulatory process for its SOLO Micro-Modular Reactor (MMR). The company announced that several technical documents are now under review by the U.S. Nuclear Regulatory Commission (NRC), following the submission of its Regulatory Engagement Plan in January 2025. This step is part of Terra Innovatum’s efforts to establish a licensing framework for its non-power reactor. Additionally, Terra Innovatum has entered into a Memorandum of Understanding with Paragon Energy Solutions. This agreement focuses on integrating NRC-approved safety systems and manufacturing support into Terra Innovatum’s SOLO reactor. The collaboration aims to enhance the design and functionality of the reactor, which the company plans to deploy commercially by 2028. These developments are part of Terra Innovatum’s ongoing strategy to advance its reactor technology.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.